US2017183663A1PendingUtilityA1

Fluorescent fusion polypeptides and methods of use

Assignee: STC UNMPriority: Apr 30, 2010Filed: Dec 30, 2016Published: Jun 29, 2017
Est. expiryApr 30, 2030(~3.7 yrs left)· nominal 20-yr term from priority
C12N 15/63C12N 15/62C07K 16/32C07K 16/30C07K 2319/60G01N 33/53G01N 33/582C07K 2317/62A61K 49/0045C07K 2319/00C07K 16/18C07K 2317/622A61K 49/0058A61N 5/062C07K 14/001C12Q 1/04
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Embodiments of the present invention provide for the facile generation of a stable recombinant fusion polypeptides with intrinsic fluorescent properties. The recombinant antibodies may be suitable for qualitative and/or quantitative immunofluorescence analysis. Generally, the fluorescent polypeptides include a fluorescent domain comprising a C-terminus and an N-terminus; a first antibody domain covalently linked to the C-terminus; and a second antibody domain covalently linked to the N-terminus.

Claims

exact text as granted — not AI-modified
1 - 18 . (canceled) 
     
     
         19 . A polynucleotide that encodes the polypeptide comprising:
 a fluorescent domain comprising a C-terminus and an N-terminus;   a first antibody domain covalently linked to the C-terminus; and   a second antibody domain covalently linked to the N-terminus.   
     
     
         20 . A cell comprising the polynucleotide of  claim 19 . 
     
     
         21 - 22 . (canceled) 
     
     
         23 . The cell of  claim 20  wherein the cell comprises a microbe. 
     
     
         24 . The cell of  claim 20  wherein the cell comprises a tumor cell. 
     
     
         25 . A method comprising introducing into a cell a polynucleotide that encodes a polypeptide that comprises:
 a fluorescent domain comprising a C-terminus and an N-terminus;   a first antibody domain covalently linked to the C-terminus; and   a second antibody domain covalently linked to the N-terminus.   
     
     
         26 . The method of  claim 25  wherein the cell comprises a tumor cell. 
     
     
         27 - 51 . (canceled) 
     
     
         52 . A method of making a fusion polypeptide, the method comprising:
 creating an expression vector that comprises a polynucleotide operably linked to a promoter, wherein the polynucleotide encodes an fusion polypeptide comprising:
 a fluorescent domain comprising a C-terminus and an N-terminus; 
 a first antibody domain covalently linked to the C-terminus; and 
 a second antibody domain covalently linked to the N-terminus; 
   introducing the expression vector into a host cell; and   growing the host cell comprising the expression vector in conditions effective for the host cell to express the fusion polypeptide.

Join the waitlist — get patent alerts

Track US2017183663A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.